华富中证港股通创新药指数型发起式A(024363)申购赎回 |
|
|
| 报告期 |
期初总份额(份) |
期末总份额(份) |
期间总申购份额(份) |
期间总赎回份额(份) |
期间净申赎份额(份) |
净申赎比例 |
| 2026/6/30 |
11,731,000 |
12,718,600 |
3,151,460 |
2,163,890 |
987,570 |
8.42% |
| 2026/6/30 |
11,967,400 |
12,718,600 |
1,993,650 |
1,242,510 |
751,140 |
6.28% |
| 2026/3/31 |
11,731,000 |
11,967,400 |
1,157,810 |
921,376 |
236,434 |
2.02% |
| 2025/12/31 |
10,016,100 |
11,731,000 |
7,499,230 |
5,784,350 |
1,714,880 |
17.12% |
| 2025/12/31 |
11,951,600 |
11,731,000 |
1,091,280 |
1,311,940 |
-220,660 |
-1.85% |
| 2025/9/30 |
10,652,300 |
11,951,600 |
5,548,850 |
4,249,520 |
1,299,330 |
12.2% |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。